We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+22.18%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$348M
AUM Growth
+$62.6M
Cap. Flow
+$45.9M
Cap. Flow %
13.19%
Top 10 Hldgs %
43.07%
Holding
103
New
27
Increased
20
Reduced
28
Closed
24

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$12.3M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$4M
3
MZOR
Mazor Robotics Ltd.
MZOR
+$3.63M
4
ALB icon
Albemarle
ALB
+$3.45M
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$3.41M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.67M
2
ADSK icon
Autodesk
ADSK
+$4.19M
3
MDCO
Medicines Co
MDCO
+$4.13M
4
Z icon
Zillow
Z
+$3.6M
5
SHOP icon
Shopify
SHOP
+$2.96M

Sector Composition

Rank Sector Weight
1 Healthcare 27.47%
2 Communication Services 13.17%
3 Technology 13.06%
4 Consumer Discretionary 5.1%
5 Materials 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
101
DELISTED
TESARO, Inc.
TSRO
– –
-14,500
Closed -$2.03M
FINL
102
PUT
DELISTED
Finish Line
FINL
– –
-63,700
Closed -$902K
NDRM
103
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
– –
-54,000
Closed -$1.61M
1 2 3 4
5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Atika Capital Management held 103 positions worth $348M, up 22% from $285M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Atika Capital Management deployed $45.9M of net new capital in Q3 2017, opening 27 new positions and adding to 20 existing holdings. Its largest new stake was Sarepta Therapeutics: 100,000 shares worth $4.54M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Autodesk, an estimated $4.19M trimmed.

  • Atika Capital Management's largest Q3 2017 buy was Sarepta Therapeutics: 100,000 shares worth $4.54M.
  • Atika Capital Management added most to Intuitive Surgical in Q3 2017, an estimated $12.3M increase.
  • Atika Capital Management's biggest Q3 2017 reduction was Autodesk, cutting an estimated $4.19M.
  • Atika Capital Management fully exited Regeneron Pharmaceuticals in Q3 2017, selling an estimated $4.67M.
  • Atika Capital Management's ten largest holdings make up 43% of its $348M portfolio in Q3 2017.
  • Atika Capital Management opened 27 new positions and closed 24 in Q3 2017.
  • Atika Capital Management's portfolio value rose 22% quarter-over-quarter to $348M.

Based on Atika Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.